COFCO Capital Holdings Co., Ltd. (002423.SZ)

CNY 14.29

(0.0%)

Revenue Summary of COFCO Capital Holdings Co., Ltd.

  • COFCO Capital Holdings Co., Ltd.'s latest annual revenue in 2023 was 24.37 Billion CNY , up 19.47% from previous year.
  • COFCO Capital Holdings Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 7.09 Billion CNY , up 5.69% from previous quarter.
  • COFCO Capital Holdings Co., Ltd. reported a annual revenue of 18.6 Billion CNY in annual revenue 2022, down -5.58% from previous year.
  • COFCO Capital Holdings Co., Ltd. reported a annual revenue of 19.7 Billion CNY in annual revenue 2021, up 45.25% from previous year.
  • COFCO Capital Holdings Co., Ltd. reported a quarterly revenue of 6.34 Billion CNY for 2024 Q1, up 26.88% from previous quarter.
  • COFCO Capital Holdings Co., Ltd. reported a quarterly revenue of 7.09 Billion CNY for 2024 Q3, up 5.69% from previous quarter.

Annual Revenue Chart of COFCO Capital Holdings Co., Ltd. (2023 - 2007)

Historical Annual Revenue of COFCO Capital Holdings Co., Ltd. (2023 - 2007)

Year Revenue Revenue Growth
2023 24.37 Billion CNY 19.47%
2022 18.6 Billion CNY -5.58%
2021 19.7 Billion CNY 45.25%
2020 13.56 Billion CNY 20.52%
2019 11.25 Billion CNY 997.78%
2018 1.02 Billion CNY 5.41%
2017 972.92 Million CNY 11.29%
2016 874.21 Million CNY -8.41%
2015 954.47 Million CNY -21.67%
2014 1.21 Billion CNY -7.4%
2013 1.31 Billion CNY -29.04%
2012 1.85 Billion CNY 6.77%
2011 1.73 Billion CNY 23.43%
2010 1.4 Billion CNY -15.72%
2009 1.66 Billion CNY 2.88%
2008 1.62 Billion CNY 24.89%
2007 1.29 Billion CNY 0.0%

Peer Revenue Comparison of COFCO Capital Holdings Co., Ltd.

Name Revenue Revenue Difference
Hubei Biocause Pharmaceutical Co., Ltd. 49.72 Billion CNY 50.979%